Hologic (HOLX) Wins Appeal on Patent Validity for SenoRx Case; Invalid Ruling Reversed
- ExxonMobil (XOM) Posts Q2 EPS of $1.00
- TerraForm Global (GLBL) IPO Opens at $14
- Unusual 11 Mid-Day Movers 7/31: (YRCW) (MGI) (HTCH) Higher; (EYEG) (RADA) (OCN) Lower
- UPS (UPS) to Acquire Coyote Logistics in $1.8B Deal
Bloomberg reporting that Hologic (Nasdaq: HOLX) has won an appeal on patent validity in its SenoRx case.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SoulCycle Files for $100M Common Stock IPO
- FedEx (FDX) Still Sees Completing TNT Express Deal in H116
- ITT Corp. (ITT) Files 10-Q, Shows Subpoena from DoD